1
|
Pachinis V, Mankoo B and Costatini F:
Expression of the c-ret proto-oncogene during mouse
embryogenesis. Development. 19:1005–1017. 1993.
|
2
|
Avantaggiato V, Dathan NA, Griero M,
Fabien N, Lazzaro D, Fusco A, Simeone A and Santoro M:
Developmental expression of the RET protooncogene. Cell
Growth Differ. 5:305–311. 1994.
|
3
|
Schuchardt A, D’Agati V, Larsson-Blomberg
L, Costantini F and Pachnis V: Defects in the kidney and enteric
nervous system of mice lacking the tyrosine kinase receptor Ret.
Nature. 367:380–383. 1994. View
Article : Google Scholar : PubMed/NCBI
|
4
|
Grieco M, Santoro M, Berlingieri MT,
Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G,
Fusco A and Vecchio G: PTC is a novel rearranged form of the
ret proto-oncogene and is frequently detected in vivo in
human thyroid papillary carcinomas. Cell. 60:557–563.
1990.PubMed/NCBI
|
5
|
Bongarzone I, Monzini N, Borrello MG,
Carcano C, Ferraresi G, Arighi E, Mondellini P, Della Porta G and
Pierotti MA: Molecular characterization of a thyroid tumor-specific
transforming sequence formed by the fusion of ret tyrosine kinase
and the regulatory subunit RI alpha of cyclic AMP-dependent protein
kinase A. Mol Cell Biol. 13:358–366. 1993.
|
6
|
Bongarzone I, Butti MG, Coronelli S,
Borrello MG, Santoro M, Mondellini P, Pilotti S, Fusco A, Della
Porta G and Pierotti MA: Frequent activation of ret
protooncogene by fusion with a new activating gene in papillary
thyroid carcinomas. Cancer Res. 54:2979–2985. 1994.PubMed/NCBI
|
7
|
Santoro M, Dathan N, Berlingieri MT,
Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G and Fusco
A: Molecular characterization of RET/PTC3; a novel
rearranged version of the RET proto-oncogene in a human
thyroid papillary carcinoma. Oncogene. 9:509–516. 1994.
|
8
|
Tallini G and Asa SL: RET oncogene
activation in papillary thyroid carcinoma. Adv Anat Pathol.
8:345–354. 2001. View Article : Google Scholar : PubMed/NCBI
|
9
|
Arighi E, Borrello MG and Sariola H: RET
tyrosine signaling in development and cancer. Cytokine Growth
Factor Rev. 16:441–467. 2005. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ciampi R, Giordano TJ, Wikenheiser-Brokamp
K, Koenig RJ and Nikiforov YE: HOOK3-RET: a novel type of
RET/PTC rearrangement in papillary thyroid carcinoma. Endocr
Relat Cancer. 14:445–452. 2007. View Article : Google Scholar
|
11
|
Fugazzola L, Pierotti MA, Vigano E, Pacini
F, Vorontsova TV and Bongarzone I: Molecular and biochemical
analysis of RET/PTC4, a novel oncogenic rearrangement between RET
and ELE1 genes, in a post-Chernobyl papillary thyroid cancer.
Oncogene. 13:1093–1097. 1996.
|
12
|
Klugbauer S, Demidchik EP, Lengfelder E
and Rabes HM: Detection of a novel type of RET rearrangement
(PTC5) in thyroid carcinomas after Chernobyl and analysis of the
involved RET-fusion gene RFG5. Cancer Res.
58:198–203. 1998.PubMed/NCBI
|
13
|
Klugbauer S and Rabes HM: The
transcription coactivator HTIF1 and a related protein are
fused to the RET receptor tyrosine kinase in childhood
papillary thyroid carcinomas. Oncogene. 18:4388–4393. 1999.
|
14
|
Klugbauer S, Jauch A, Lengfelder E,
Demidchik E and Rabes HM: A novel type of RET rearrangement
(PTC8) in childhood papillary thyroid carcinomas and
characterization of the involved gene (RFG8). Cancer Res.
60:7028–7032. 2000.
|
15
|
Salassidis K, Bruch J, Zitzelsberger H,
Lengfelder E, Kellerer AM and Bauchinger M: Translocation
t(10;14)(q11.2:q22.1) fusing the kinetin to the RET
gene creates a novel rearranged form (PTC8) of the RET
proto-oncogene in radiation-induced childhood papillary thyroid
carcinoma. Cancer Res. 60:2786–2789. 2000.
|
16
|
Corvi R, Berger N, Balczon R and Romeo G:
RET/PCM-1: a novel fusion gene in papillary thyroid cancer.
Oncogene. 19:4236–4242. 2000. View Article : Google Scholar
|
17
|
Saenko V, Rogounovitch T, Shimizu-Yoshida
Y, Abrosimov A, Lushnikov E, Roumiantsev P, Matsumoto N, Nakashima
M, Merimanov S, Ohtsuru A, Namba H, Tsyb A and Yamashita S: Novel
tumorigenic rearrangement, Δ rfp/ret, in a papillary thyroid
carcinoma from externally irradiated patient. Mutat Res. 527:81–90.
2003.
|
18
|
Hamatani K, Eguchi E, Ito R, Mukai M,
Takahashi K, Taga M, Imai K, Cologne J, Soda M, Arihiro K, Fujihara
M, Abe K, Hayashi T, Nakashima M, Sekine I, Yasui W, Hayashi Y and
Nakachi K: RET/PTC rearrangements preferentially occurred in
papillary thyroid cancer among atomic bomb survivors exposed to
high radiation dose. Cancer Res. 68:7176–7182. 2008. View Article : Google Scholar
|
19
|
Hamatani K, Mukai M, Takahashi K, Hayashi
Y, Nakachi K and Kusunoki Y: Rearranged anaplastic lymphoma kinase
(ALK) gene in adult-onset papillary thyroid cancer amongst
atomic bomb survivors. Thyroid. 22:1153–1159. 2012.PubMed/NCBI
|
20
|
Hamatani K, Eguchi H, Taga M, Mukai M,
Koyama K, Hayashi Y and Nakachi K: Improved method for analysis of
RNA present in long-term preserved thyroid cancer tissue of
atomic-bomb survivors. Thyroid. 20:43–49. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Young RW and Kerr GD: Reassessment of the
Atomic Bomb Radiation Dosimetry for Hiroshima and Nagasaki -
Dosimetry System 2002. 1. Radiation Effects Research Foundation;
Hiroshima, Japan: 2005
|
22
|
Hamatani K, Eguchi H, Takahashi K, Koyama
K, Mukai M, Ito R, Taga M, Yasui W and Nakachi K: Improved RT-PCR
amplification for molecular analyses with long-term preserved
formalin-fixed, paraffin-embedded tissue specimens. J Histochem
Cytochem. 54:773–780. 2006. View Article : Google Scholar
|
23
|
Tong Q, Xing S and Jhiang SM: Leucine
zipper-mediated dimerization is essential for the PTC1
oncogenic activity. J Biol Chem. 272:9043–9047. 1997. View Article : Google Scholar : PubMed/NCBI
|
24
|
Alberti L, Carniti C, Miranda C, Roccato E
and Pierotti M: RET and NTRK1 proto-oncogenes in human diseases. J
Cell Physiol. 195:168–186. 2003. View Article : Google Scholar : PubMed/NCBI
|
25
|
Kodama Y, Asai N, Kawai K, Jijiwa M,
Murakumo Y, Ichihara M and Takahashi M: The RET
proto-oncogene: a molecular therapeutic target in thyroid cancer.
Cancer Sci. 96:143–148. 2005.PubMed/NCBI
|